You can seek FDA approval to launch a generic drug before the expiration of BOSULIF's patents related by providing a 'paragraph IV certification' in your application, which states that the patent submitted by the BOSULIF's sponsor is invalid, unenforceable, or will not be infringed by your generic product.

Here are the details of the already filed Para IV certificates on BOSULIF:-

You can seek FDA approval to launch a generic drug before the expiration of BRILINTA's patents related by providing a 'paragraph IV certification' in your application, which states that the patent submitted by the BRILINTA's sponsor is invalid, unenforceable, or will not be infringed by your generic product.

Here are the details of the already filed Para IV certificates on BRILINTA:-

You can seek FDA approval to launch a generic drug before the expiration of EMEND's patents related by providing a 'paragraph IV certification' in your application, which states that the patent submitted by the EMEND's sponsor is invalid, unenforceable, or will not be infringed by your generic product.

Here are the details of the already filed Para IV certificates on EMEND:-

You can seek FDA approval to launch a generic drug before the expiration of EVOTAZ's patents related by providing a 'paragraph IV certification' in your application, which states that the patent submitted by the EVOTAZ's sponsor is invalid, unenforceable, or will not be infringed by your generic product.

Here are the details of the already filed Para IV certificates on EVOTAZ:-

You can seek FDA approval to launch a generic drug before the expiration of GILOTRIF's patents related by providing a 'paragraph IV certification' in your application, which states that the patent submitted by the GILOTRIF's sponsor is invalid, unenforceable, or will not be infringed by your generic product.

Here are the details of the already filed Para IV certificates on GILOTRIF:-

You can seek FDA approval to launch a generic drug before the expiration of GLEEVEC's patents related by providing a 'paragraph IV certification' in your application, which states that the patent submitted by the GLEEVEC's sponsor is invalid, unenforceable, or will not be infringed by your generic product.

Here are the details of the already filed Para IV certificates on GLEEVEC:-

You can seek FDA approval to launch a generic drug before the expiration of LATUDA's patents related by providing a 'paragraph IV certification' in your application, which states that the patent submitted by the LATUDA's sponsor is invalid, unenforceable, or will not be infringed by your generic product.

Here are the details of the already filed Para IV certificates on LATUDA:-

You can seek FDA approval to launch a generic drug before the expiration of LYRICA CR's patents related by providing a 'paragraph IV certification' in your application, which states that the patent submitted by the LYRICA CR's sponsor is invalid, unenforceable, or will not be infringed by your generic product.

Here are the details of the already filed Para IV certificates on LYRICA CR:-

You can seek FDA approval to launch a generic drug before the expiration of NEXIUM 24HR's patents related by providing a 'paragraph IV certification' in your application, which states that the patent submitted by the NEXIUM 24HR's sponsor is invalid, unenforceable, or will not be infringed by your generic product.

Here are the details of the already filed Para IV certificates on NEXIUM 24HR:-

You can seek FDA approval to launch a generic drug before the expiration of OTEZLA's patents related by providing a 'paragraph IV certification' in your application, which states that the patent submitted by the OTEZLA's sponsor is invalid, unenforceable, or will not be infringed by your generic product.

Here are the details of the already filed Para IV certificates on OTEZLA:-

You can seek FDA approval to launch a generic drug before the expiration of PROMACTA KIT's patents related by providing a 'paragraph IV certification' in your application, which states that the patent submitted by the PROMACTA KIT's sponsor is invalid, unenforceable, or will not be infringed by your generic product.

Here are the details of the already filed Para IV certificates on PROMACTA KIT:-

You can seek FDA approval to launch a generic drug before the expiration of REYATAZ's patents related by providing a 'paragraph IV certification' in your application, which states that the patent submitted by the REYATAZ's sponsor is invalid, unenforceable, or will not be infringed by your generic product.

Here are the details of the already filed Para IV certificates on REYATAZ:-

You can seek FDA approval to launch a generic drug before the expiration of SPIRIVA RESPIMAT's patents related by providing a 'paragraph IV certification' in your application, which states that the patent submitted by the SPIRIVA RESPIMAT's sponsor is invalid, unenforceable, or will not be infringed by your generic product.

Here are the details of the already filed Para IV certificates on SPIRIVA RESPIMAT:-

You can seek FDA approval to launch a generic drug before the expiration of TRIUMEQ's patents related by providing a 'paragraph IV certification' in your application, which states that the patent submitted by the TRIUMEQ's sponsor is invalid, unenforceable, or will not be infringed by your generic product.

Here are the details of the already filed Para IV certificates on TRIUMEQ:-

You can seek FDA approval to launch a generic drug before the expiration of VYZULTA's patents related by providing a 'paragraph IV certification' in your application, which states that the patent submitted by the VYZULTA's sponsor is invalid, unenforceable, or will not be infringed by your generic product.

Here are the details of the already filed Para IV certificates on VYZULTA:-